INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 110 filers reported holding INTERSECT ENT INC in Q1 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,406,000 | -40.0% | 550,000 | -41.5% | 0.39% | -34.6% |
| Q4 2021 | $25,671,000 | -22.6% | 940,000 | -23.0% | 0.59% | -15.0% |
| Q3 2021 | $33,184,000 | +59.2% | 1,220,000 | 0.0% | 0.70% | +69.4% |
| Q2 2021 | $20,850,000 | -7.6% | 1,220,000 | +12.9% | 0.41% | -16.3% |
| Q1 2021 | $22,555,000 | +40.7% | 1,080,200 | +54.3% | 0.49% | +44.7% |
| Q4 2020 | $16,030,000 | +96.6% | 700,000 | +40.0% | 0.34% | +64.3% |
| Q3 2020 | $8,155,000 | +20.5% | 500,000 | 0.0% | 0.21% | +11.3% |
| Q2 2020 | $6,770,000 | +14.3% | 500,000 | 0.0% | 0.19% | -24.1% |
| Q1 2020 | $5,925,000 | -70.3% | 500,000 | -37.5% | 0.24% | -61.0% |
| Q4 2019 | $19,920,000 | +34.2% | 800,000 | -8.3% | 0.63% | +6.4% |
| Q3 2019 | $14,841,000 | -17.5% | 872,500 | +10.4% | 0.59% | -9.1% |
| Q2 2019 | $17,980,000 | +20.3% | 790,000 | +69.9% | 0.65% | +12.8% |
| Q1 2019 | $14,950,000 | +14.1% | 465,000 | 0.0% | 0.58% | -6.9% |
| Q4 2018 | $13,104,000 | -0.9% | 465,000 | +1.1% | 0.62% | +29.2% |
| Q3 2018 | $13,225,000 | -13.9% | 460,000 | +12.2% | 0.48% | -19.0% |
| Q2 2018 | $15,355,000 | -4.7% | 410,000 | 0.0% | 0.59% | -14.0% |
| Q1 2018 | $16,113,000 | +44.1% | 410,000 | +18.8% | 0.69% | +35.5% |
| Q4 2017 | $11,178,000 | +4.0% | 345,000 | 0.0% | 0.51% | +2.2% |
| Q3 2017 | $10,747,000 | +11.4% | 345,000 | 0.0% | 0.50% | +1.8% |
| Q2 2017 | $9,643,000 | +63.0% | 345,000 | 0.0% | 0.49% | +42.8% |
| Q1 2017 | $5,917,000 | +41.7% | 345,000 | 0.0% | 0.34% | +22.2% |
| Q4 2016 | $4,175,000 | -23.6% | 345,000 | 0.0% | 0.28% | -18.7% |
| Q3 2016 | $5,465,000 | +24.3% | 345,000 | +1.5% | 0.34% | +5.5% |
| Q2 2016 | $4,396,000 | -32.0% | 340,000 | 0.0% | 0.32% | -39.9% |
| Q1 2016 | $6,460,000 | -14.9% | 340,000 | +0.8% | 0.54% | -5.9% |
| Q4 2015 | $7,589,000 | +36.5% | 337,293 | +42.0% | 0.58% | +27.5% |
| Q3 2015 | $5,558,000 | +10.9% | 237,500 | +35.7% | 0.45% | +23.2% |
| Q2 2015 | $5,010,000 | – | 175,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |